Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hugh McTavish, PhD, JD
Squarex, LLC
Study Director - Thomas D Horn, MD
Squarex, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Medicine Outpatient Center
Redwood City, California, United States
- International Research Partners, Llc
Doral, Florida, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Quality Clinical Research, Inc
Omaha, Nebraska, United States
- Advantage Clinical Trials
The Bronx, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2016
- Primary completion
- 20 Dec 2018
- Completion
- 20 Dec 2018
- Last update posted
- 2 Nov 2021
- Registered enrollment
- 139
- Registry id
- NCT02965781
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.